Abstract
Five novel metalloproteinase protein inhibitors (MPIs) with molecular mass between 5.6 and 8.9 kDa and acid/neutral pI were detected in lupin seeds and exhibited strong inhibitory activities against thermolysin and/or gelatinase B. These novel peptides constitute not only the first MPIs described in plants but also the first plant peptides with inhibitory activity against a matrixin.
Keywords: Gelatinase B, lupin quiescent seed, matrixin peptide inhibitor, metalloproteinase protein inhibitor (MPI), thermolysin
Protein & Peptide Letters
Title: Discovery of Novel Plant Peptides as Strong Inhibitors of Metalloproteinases
Volume: 16 Issue: 5
Author(s): Dina M. Carrilho, Isabel C. Duarte, Rita Francisco, Candido P.P. Ricardo and Maria C. Duque-Magalhaes
Affiliation:
Keywords: Gelatinase B, lupin quiescent seed, matrixin peptide inhibitor, metalloproteinase protein inhibitor (MPI), thermolysin
Abstract: Five novel metalloproteinase protein inhibitors (MPIs) with molecular mass between 5.6 and 8.9 kDa and acid/neutral pI were detected in lupin seeds and exhibited strong inhibitory activities against thermolysin and/or gelatinase B. These novel peptides constitute not only the first MPIs described in plants but also the first plant peptides with inhibitory activity against a matrixin.
Export Options
About this article
Cite this article as:
Carrilho M. Dina, Duarte C. Isabel, Francisco Rita, Ricardo P.P. Candido and Duque-Magalhaes C. Maria, Discovery of Novel Plant Peptides as Strong Inhibitors of Metalloproteinases, Protein & Peptide Letters 2009; 16 (5) . https://dx.doi.org/10.2174/092986609788167789
DOI https://dx.doi.org/10.2174/092986609788167789 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Applications of Muscle Electroporation Gene Therapy
Current Gene Therapy <i>Uncaria tomentosa</i> (Willd. ex Schult.): Focus on Nutraceutical Aspects
Current Bioactive Compounds YB-1 Activities in Oncogenesis: Transcription and Translation
Current Cancer Therapy Reviews Transmembrane Interactions of HIV-1 Vpu and Tetherin
Current HIV Research Morpholino, siRNA, and S-DNA Compared: Impact of Structure and Mechanism of Action on Off-Target Effects and Sequence Specificity
Current Topics in Medicinal Chemistry Hyperthermia Associated Osteonecrosis in Young Patients with Pelvic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Prophylactic Vaccine Strategies and the Potential of Therapeutic Vaccines Against Herpes Simplex Virus
Current Pharmaceutical Design Potential Cancer Gene Therapy by Baculoviral Transduction
Current Gene Therapy The Cancer Preventive Effects of Edible Mushrooms
Anti-Cancer Agents in Medicinal Chemistry Future Prospect of RNA Interference for Cancer Therapies
Current Drug Targets RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
Current Medicinal Chemistry The Synthesis of Nano-Doxorubicin and its Anticancer Effect
Anti-Cancer Agents in Medicinal Chemistry HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET
Current Drug Targets An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs
Current Topics in Medicinal Chemistry Study of Splicing Factor, Proline- and Glutamine-rich by Proteomic Techniques in Human Malignant and Nonmalignant Cell Lines
Protein & Peptide Letters Fluorescence Imaging in Cancerology
Current Molecular Imaging (Discontinued) Overcoming the Drug Resistance Problem with Second-Generation Tyrosine Kinase Inhibitors: From Enzymology to Structural Models
Current Medicinal Chemistry Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways
Current Pharmaceutical Design Development of Hedgehog Pathway Inhibitors (HPI) in Treatment of Cancer
Current Chemical Biology Biosafety of Lentiviral Vectors
Current Gene Therapy